Ipsogen SA (Alternext: ALIPS) today announced that a new study confirming the pivotal role of tumor grade in chemotherapy prescription has been presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS), December 9-13, 2009.

Viterbi School biomedical engineer and cardiologist Tzung John Hsiai hopes to develop a new tool to help clinicians distinguish cardiac emergencies requiring immediate surgery from chronic problems manageable with drugs and lifestyle change.

A major clinical challenge is to find the best method to evaluate and to manage the increasing numbers of patients with chronic liver disease. Liver biopsy, due to its risks and limitations, is no longer considered mandatory as the first-line indicator of liver injury, and several markers have been developed as non-invasive alternatives.

Geneva, Switzerland: Research by scientists in France has shown for the first time that identifying patterns of gene expression can be used to predict response to treatment in patients with advanced metastatic colorectal cancer.

Delivers powerful combination of the highest sensitivity in the industry, next generation of MotionFree technology, high definition imaging, fast reconstruction with the IBM BladeCenter®
Continuing its leadership in PET/CT technology, GE Healthcare announced the introduction of Discovery PET/CT 600, GE Healthcare’s newest positron emission tomography/computed tomography (PET/CT) system at the annual meeting of the European Association [...]